Natriumklorid Fresenius Kabi (Sodium Chloride)

The product provides isotonic sodium (Na⁺) and chloride (Cl⁻) ions directly into the bloodstream. These ions increase extracellular osmolarity, drawing water into the vascular space, expanding plasma volume, and correcting sodium‑chloride deficits without shifting intracellular fluid.

The prescribed dose is determined by the treating physician based on the patient’s clinical condition, fluid losses, and electrolyte status. Dosing is individualized and may be adjusted according to ongoing monitoring of vital signs and laboratory values.

Safety data for this specific formulation in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Natriumklorid is an isotonic saline solution that provides only sodium and chloride, making it a simple electrolyte replacement. Compared with balanced solutions that contain additional ions (e.g., potassium, calcium, lactate), it is useful when only NaCl correction is needed, but it may lack the buffering capacity of balanced crystalloids.

The product must be stored at 2‑8 °C, protected from light, and should not be frozen or shaken. Keep the vial in its original packaging until use and discard any solution that appears cloudy, discolored, or contains particles.

Natriumklorid is administered intravenously, typically via a peripheral or central vein. The infusion rate is set by the prescriber and may be adjusted according to the patient’s hemodynamic response and laboratory results. Administration should follow aseptic technique and standard IV infusion protocols.

Serious risks include severe hypernatremia, fluid overload leading to pulmonary edema, and rare anaphylactoid reactions. Continuous monitoring of fluid balance, vital signs, and serum electrolytes is essential to detect and manage these complications promptly.

Patients with known hypersensitivity to sodium chloride solutions, those with uncontrolled hypernatremia, or individuals for whom fluid overload would be dangerous (e.g., severe heart failure) should not receive this product unless a careful risk‑benefit assessment is performed by a qualified clinician.